The host environment drives HIV-1 fitness

被引:23
作者
van Opijnen, T
Berkhout, B
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Sect Populat Biol, Inst Biodivers & Ecosyst Dynam, NL-1098 SM Amsterdam, Netherlands
关键词
D O I
10.1002/rmv.472
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Viral fitness is defined by the ability of an individual genotype to produce infectious progeny in a specific environment. For HIV the environment is never constant but rather fluctuates in time and space. For instance, environmental factors that determine viral fitness during transmission from host to host are different to the pressures from either cytotoxic T-lymphocytes (CTLs) or antiviral drugs. Consequently, viral fitness is highly dependent on the environment and the accurate determination of this value therefore depends strongly on the chosen environmental setting. This review describes how the host environment imposes selective pressures on the virus that shape its genotype and fitness. The most important environments that the virus encounters throughout its life cycle and during natural infection are discussed. In order of appearance, CTLs are discussed, followed by neutralising antibodies and antiretroviral drug treatment. It then goes on to describe receptor molecules that mediate viral entry and intracellular restriction factors, which represent selective pressures that are present directly from the start of a natural infection. It concludes by discussing the complexity of viral fitness and how an accurate measure of viral fitness eventually may, for example, contribute to the improvement of antiretroviral therapy or help in the formulation of an optimal vaccination strategy. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:219 / 233
页数:15
相关论文
共 150 条
[1]   HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS [J].
Abebe, A ;
Demissie, D ;
Goudsmit, J ;
Brouwer, M ;
Kuiken, CL ;
Pollakis, G ;
Schuitemaker, H ;
Fontanet, AL ;
de Wit, TFR .
AIDS, 1999, 13 (11) :1305-1311
[2]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[3]   PERSISTENCE OF AZIDOTHYMIDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA GENOTYPES IN POSTTREATMENT SERA [J].
ALBERT, J ;
WAHLBERG, J ;
LUNDEBERG, J ;
COX, S ;
SANDSTROM, E ;
WAHREN, B ;
UHLEN, M .
JOURNAL OF VIROLOGY, 1992, 66 (09) :5627-5630
[4]   Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection [J].
Alexander, L ;
Weiskopf, E ;
Greenough, TC ;
Gaddis, NC ;
Auerbach, MR ;
Malim, MH ;
O'Brien, SJ ;
Walker, BD ;
Sullivan, JL ;
Desrosiers, RC .
JOURNAL OF VIROLOGY, 2000, 74 (09) :4361-4376
[5]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[6]   Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia [J].
Allen, TM ;
O'Connor, DH ;
Jing, PC ;
Dzuris, JL ;
Mothé, BR ;
Vogel, TU ;
Dunphy, E ;
Liebl, ME ;
Emerson, C ;
Wilson, N ;
Kunstman, KJ ;
Wang, XC ;
Allison, DB ;
Hughes, AL ;
Desrosiers, RC ;
Altman, JD ;
Wolinsky, SM ;
Sette, A ;
Watkins, DI .
NATURE, 2000, 407 (6802) :386-390
[7]  
Aquaro S, 1998, J BIOL REG HOMEOS AG, V12, P23
[8]   Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes [J].
Aquaro, S ;
Perno, CF ;
Balestra, E ;
Balzarini, J ;
Cenci, A ;
Francesconi, M ;
Panti, S ;
Serra, F ;
Villani, N ;
Calio, R .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (01) :138-143
[9]   Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture [J].
Archer, RH ;
Dykes, C ;
Gerondelis, P ;
Lloyd, A ;
Fay, P ;
Reichman, RC ;
Bambara, RA ;
Demeter, LM .
JOURNAL OF VIROLOGY, 2000, 74 (18) :8390-8401
[10]   NEUTRALIZING ANTIBODY-RESPONSE DURING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - TYPE AND GROUP SPECIFICITY AND VIRAL ESCAPE [J].
ARENDRUP, M ;
SONNERBORG, A ;
SVENNERHOLM, B ;
AKERBLOM, L ;
NIELSEN, C ;
CLAUSEN, H ;
OLOFSSON, S ;
NIELSEN, JO ;
HANSEN, JES .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :855-863